Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium and SSRI vs SSRI alone in Major Depressive Disorder
NCT07458022Phase 2Active, not recruiting
- Sponsor
- University of Child Health Sciences and Children's Hospital, Lahore
- Start
- Dec 2025
- Primary completion
- Apr 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of magnesium in major depressive disorder (MDD), sponsored by University of Child Health Sciences and Children's Hospital, Lahore. Started Dec 2025; status: active, not recruiting.
02
Drugs
magnesium
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07458022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07458022.